Folate and ApoE DNA methylation induced by homocysteine in human monocytes

DNA and Cell Biology

Volumn 26, Issue 10, 2007, Pages 737-744

  Yi Deng, Jiang ^a   Tao, Sun ^a   Hui Ping, Zhang ^b   Jian Tuan, Xiong ^a   Jun, Cao ^a   Gui Zhong, Li ^a   Shu Ren, Wang ^c  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b Yin Chuan Maternal and Child Health Hospital   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER; FOLIC ACID; HOMOCYSTEINE; CHOLESTEROL; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA METHYLATION; DRUG ACTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; FOAM CELL; GENETICS; LIPID METABOLISM; METABOLISM; MONOCYTE; PROMOTER REGION;

APOLIPOPROTEINS E; CELLS, CULTURED; CHOLESTEROL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FOAM CELLS; FOLIC ACID; HOMOCYSTEINE; HUMANS; LIPID METABOLISM; MONOCYTES; PROMOTER REGIONS (GENETICS);

EID: 38449118658     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0619     Document Type: Article

References (41)

1. Domagala, T.B., Undas, A., Libura, M., and Szczeklik, A. (1998). Pathogenesis of vascular disease in hyperhomocysteinaemia [Review]. J Cardiovasc Risk 5, 239-247.
2. Forte, T.M., Subbanagounder, G., Berliner, J.A., Blanche, P.J., Clermont, A.O., Jia, Z., Oda, M.N., Krauss, R.M., and Bielicki, J.K. (2002). Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J Lipid Res 43, 477-485.
3. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., den Heijer, M., Kluijtmans, L.A.J., van den Heuve, L.P., and Rozen, R. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
4. Gao, J., Morrison, D.C., Parmely, T.J., Russell, S.W., and Murphy, W.J. (1997). An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J Biol Chem 272, 1226-1230.
5. Gatto, L., Berlato, C., Poli, V., Tininini, S., Kinjyo, I., Yoshimura, A., Cassatella, M.A., and Bazzoni, F. (2004). Analysis of SOCS-3 promoter responses to interferon gamma. J Biol Chem 279, 13746-13754.
6. Gretch, D.G., Sturley, S.L., and Attie, A.D. (1995). Human apolipoprotein E mediates processive buoyant lipoprotein formation in insect larvae. Biochemistry 34, 545-552.
7. Hanon, O., Girerd, X., Luong, V., Jeunemaitre, X., Laurent, S., and Safar, M.E. (2000). Association between the apolipoprotein E polymorphism and arterial wall in asymptomatic adults. J Hypertens 18, 431-436.
8. Hasty, A.H., Linton, M.F., Brandt, S.J., Babaev, V.R., Gleaves, L.A., and Fazio, S. (1999). Retroviral gene therapy in apoE-deficient mice: apoE expression in the artery wall reduces early foam cell lesion formation. Circulation 99, 2571-2576.
9. Hasty, A.H., Plummer, M.R., Weisgraber, K.H., Linton, M.F., Fazio, S., and Swift, L.L. (2005). The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. J Lipid Res 46, 1433-1439.
10. Huang, Y., Ji, Z.S., Brecht, W.J., Rall, S.C., Taylor, J.M., and Mahley, R.W. (1999). Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Arterioscler Thromb Vasc Biol 19, 2952-2959.
11. Huang, Y., Peng, K., Su, J., Huang, Y., Xu, Y., and Wang, S. (2007). Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor a gene. Acta Biochim Biophys Sin 39, 19-26.
12. Hunt, M.J., and Tyagi, S.C. (2002). Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation. Am J Physiol 283, 1073-1079.
13. Issa, J.P., Vertino, P.M., Wu, J., Sazawal, S., Celano, P., Nelkin, B.D., Hamilton, S.R., and Baylin, S.B. (1993). Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85, 1235-1240.
14. James, S.J., Melnyk, S., Pogribna, M., Pogribny, I.P., and Caudill, M.A. (2002). Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132, 2361S-2366S.
15. Ji, Z.S., Dichek, H.L., Miranda, R.D., and Mahley, R.W. (1997). Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem 272, 31285-31292.
16. Jiang, Y., Zhang, J., Xiong, J., Cao, J., Li, G., and Wang, S. (2007). Ligands of peroxisome proliferator-activated receptor inhibit homocysteine induced DNA methylation of inducible nitric oxide synthase. Acta Biochim Biophys Sin (Shanghai) 39, 366-376.
17. Kim, Y.I., Christman, J.K., Fleet, J.C., Cravo, M.L., Salomon, R.N., Smith, D., Ordovas, J., Selhub, J., and Mason, J.B. (1995). Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am J Clin Nutr 61, 1083-1090.
18. Koo, C., Innerarity, T.L., and Mahley, R.W. (1985). Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem 60, 11934-11943.
19. Kuipers, F., Jong, M.C., Lin, Y., Eck, M., Havinga, R., Bloks, V., Verkade, H.J., Hofker, M.H., Moshage, H., Berkel, T.J., Vonk, R.J., and Havekes, L.M. (1997). Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J Clin Invest 100, 2915-2922.
20. Lin, C.Y., Duan, H.W., and Mazzone, T. (1999). Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J Lipid Res 40, 1618-1626.
21. Linton, M.F., Atkinson, J.B., and Fazio, S. (1995). Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 267, 1034-1037.
22. Mahley, R.W., and Rall, S.C., Jr. (2000). Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507-537.
23. Marathe, S., Choi, Y., Leventhal, A., and Tabas, I. (2000). Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophages foam cell formation. Arterioscler Thromb Vasc Biol 20, 2607-2613.
24. Melnyk, S., Pogribna, M., Pogribny, I.P., Yi, P., and James, S.J. (2000). Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 50-phosphate concentrations. Clin Chem 46, 265-272.
25. Mensenkamp, A.R., Jong, M.C., van Goor, H., van Luyn, M.J., Bloks, V., Havinga, R., Voshol, P.J., Hofker, M.H., van Dijk, K.W., Havekes, L.M., and Kuipers, F. (1999). Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J Biol Chem 274, 35711-35718.
26. Pang, Z.J., Zhou, M., and Chen, Y., eds. (2000). Free Radical Medicine Study Method, First edition (People's Medical Publishing House, Beijing) pp. 38, 24-32.
27. Refsum, H., Ueland, P.M., Nygård, O., and Vollset, S.E. (1998). Homocysteine and cardiovascular disease. Annu Rev Med 49, 31-62.
28. Sass, C., Zannad, F., Herbeth, B., Salah, D., Chapet, O., Siest, G., and Visvikis, S. (1998). Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis 140, 89-95.
29. Spangenberg, J., and Curtiss, L.K. (1997). Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice. Biochim Biophys Acta 1349, 109-121.
30. Tabas, I., Lim, S., Xu, X.X., and Maxfield, F.R. (1990). Endocytosed β-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages. J Cell Biol 111, 929-940.
31. Tabas, I., Myers, J.N., Innerarity, T.L., Xu, X.X., Arnold, K., Boyles, J., and Maxfield, F.R. (1991). The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages. J Cell Biol 115, 1547-1560.
32. Trasler, J., Deng, L., Melnyk, S., Pogribny, I., Hiou-Tim, F., Sibani, S., Oakes, C., Li, E., James, S.J., and Rozen, R. (2003). Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 24, 39-45.
33. Weisenberger, D.J., Campan, M., Long, T.I., Kim, M., Woods, C., Fiala, E., Ehrlich, M., and Laird, P.W. (2005). Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33, 6823-6836.
34. Widschwendter, M., Siegmund, K.D., Müller, H.M., Fiegl, H., Marth, C., Müller-Holzner, E., Jones, P.A., and Laird, P.W. (2004). Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64, 3807-3813.
35. Yi, P., Melnyk, S., Pogribna, M., Pogribny, I.P., Hine, R.J., and James, S.J. (2000). Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275, 29318-29323.
36. Yi-deng, J., Jian-Zhong, Z., Ying, H., Juan, S., Jin-ge, Z., Lizhen, W., Xiaoqun, H., and Shuren, W. (2007a). Homocysteine-mediated aberrant DNA methylation in vascular smooth muscle cells and its potential pathogenic mechanism. Prog Biochem Biophys 34, 1-11.
37. Yi-deng, J., Jian-Zhong, Z., Ying, H., Juan, S., Jin-ge, Z., Shenglan, W., Xiaoqun, H., and Shuren, W. (2007b). Homocysteine-mediated expression of SAHH, DNMTs, MBD2 and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 26, 603-611.
38. Yoshida, H., Hasty, A.H., Major, A.S., Ishiguro, H., Su, Y.R., Gleaves, L.A., Babaev, V.R., Linton, M.F., and Fazio, S. (2001). Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in apoE-null mice. Circulation 104, 2820-2828.
39. Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., and Lisheng, L.; INTERHEART Study Investigators (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952.
40. Zeng, X., Dai, J., Remick, D.G., and Wang, X. (2003). Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res 93, 311-320.
41. Zhu, Y., and Hui, D.Y. (2003). Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J Biol Chem 278, 36257-36263.